Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 4Breast 3Gynecologic 2Genitourinary 2Dermatologic 2Other solid neoplasm 1NET 1Head & Neck 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 389Head and Neck Neoplasms 340Carcinoma, Non-Small-Cell Lung 230Melanoma 155Colorectal Neoplasms 152Breast Neoplasms 138Ovarian Neoplasms 125Neoplasms 103Stomach Neoplasms 101Carcinoma, Renal Cell 101Neoplasm Metastasis 94Pancreatic Neoplasms 93Lung Neoplasms 87Uterine Cervical Neoplasms 81Triple Negative Breast Neoplasms 75Esophageal Neoplasms 75Prostatic Neoplasms 70Urinary Bladder Neoplasms 69Thyroid Neoplasms 62Carcinoma, Squamous Cell 57Carcinoma, Hepatocellular 57Sarcoma 54Endometrial Neoplasms 54Carcinoma, Transitional Cell 54Small Cell Lung Carcinoma 50Salivary Gland Neoplasms 49Colonic Neoplasms 41Nasopharyngeal Carcinoma 38Mouth Neoplasms 37Kidney Neoplasms 34

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Intestinal Neoplasms × Head & Neck × Clear all
NCT05544929 2026-01-06

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Novartis

Phase 1 Active not recruiting
126 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Nasopharyngeal Carcinoma, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Nasopharyngeal Neoplasms, Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Skin Neoplasms, Thymoma, Thymus Neoplasms, Colorectal Neoplasms, Adenocarcinoma, Clear Cell, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡